Track the Oncolytics Biotech Inc. stock price and the full insider trade history of the company, a listed equity based in Canada. Shares are listed on the CA market, under the supervision of SEDI. Market capitalisation: €106m. The latest transaction was disclosed on 4 June 2026 (00 - Opening Balance-Initial SEDI Report). Among the most active insiders: McAdory, John Bearden. The full history is free.
17
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Oncolytics Biotech Inc. Buy (bullish), based on 6 analysts. Average price target: US$5.15.
19Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.